Clinical Microbiology and Infection

Papers
(The H4-Index of Clinical Microbiology and Infection is 57. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
What is the evidence base of used aggregated antibiotic resistance percentages to change empirical antibiotic treatment? A scoping review706
Antimicrobial susceptibility of Mycobacterium abscessus and treatment of pulmonary and extra-pulmonary infections576
European society of clinical microbiology and infectious diseases guidelines for antimicrobial stewardship in emergency departments (endorsed by European association of hospital pharmacists)389
Acute cough in outpatients: what causes it, how long does it last, and how severe is it for different viruses and bacteria?388
Interpretation of SARS-CoV-2 replication according to RT-PCR crossing threshold value382
Mycotic aneurysm of the infrarenal abdominal aorta infected by Mycoplasma hyorhinis diagnosed with direct 16S ribosomal DNA sequencing302
Has the COVID-19 pandemic wiped out the seasonality of outpatient antibiotic use and influenza activity? A time-series analysis from 2014 to 2021269
COVID-19 in special populations241
Expected phenotypes and expert rules are important complements to antimicrobial susceptibility testing187
Post-acute COVID-19 syndrome: a new tsunami requiring a universal case definition178
Re: Diagnostic limitations and challenges in current clinical guidelines and potential application of metagenomic sequencing to manage pulmonary invasive fungal infections in patients with haematologi163
Primary antifungal prophylaxis after haematopoietic stem cell transplantation: will the search for perfection become the enemy of good?156
Corrigendum to “Dynamic transmission models and economic evaluations of pneumococcal conjugate vaccines: a quality appraisal and limitations” [Clin Microbiol and Infect 26 (1) (2020) 60–70]152
How to: Diagnose inborn errors of intrinsic and innate immunity to viral, bacterial, mycobacterial, and fungal infections151
Re: ‘The relative effectiveness of a high-dose quadrivalent influenza vaccine versus standard-dose quadrivalent influenza vaccines in older adults in France: a retrospective cohort study during the 20143
Myxovirus resistance protein A for discriminating between viral and bacterial lower respiratory tract infections in children – The TREND study138
Which trial do we need? Doxycycline in combination with ceftriaxone for the treatment of community-acquired pneumonia137
Cefiderocol for resistant Gram negatives: linking in vitro activity with clinical effectiveness129
Fecal pharmacokinetics/pharmacodynamics characteristics of fidaxomicin and vancomycin against Clostridioides difficile infection elucidated by in vivo feces-based infectious evaluation models128
Outside Front Cover124
Re: what is the role of epidemiological investigations in human Campylobacter outbreaks in the One Health and whole-genome sequencing era in Denmark?112
Should multiplex PCR testing be integrated into antimicrobial stewardship programs for paediatric community-acquired pneumonia in the emergency department?107
Recommendations for accurate genotyping of SARS-CoV-2 using amplicon-based sequencing of clinical samples105
Re: Compromised access to antibiotics: addressing paediatric challenges in availability and responsible use104
Exploring the limits of interferon-γ releasing assay screening in large-scale populations104
Measuring the impact of hospitalization for infectious diseases on the quality of life of older patients in four European countries: the AEQUI longitudinal matched cohort study (2020–2023)102
‘Introducing new antibiotics for multidrug-resistant bacteria: obstacles and the way forward’ – author's response99
Assessment of BIV1-CovIran inactivated vaccine–elicited neutralizing antibody against the emerging SARS-CoV-2 variants of concern98
Intra-host non-synonymous diversity at a neutralizing antibody epitope of SARS-CoV-2 spike protein N-terminal domain93
TMPRSS2 inhibitors for the treatment of COVID-19 in adults: a systematic review and meta-analysis of randomized clinical trials of nafamostat and camostat mesylate89
Six-month antibody response to SARS-CoV-2 in healthcare workers assessed by virus neutralization and commercial assays88
Resistance mutations in SARS-CoV-2 omicron variant in patients treated with sotrovimab88
SARS-CoV-2 specific T-cell immunity in COVID-19 convalescent patients and unexposed controls measured by ex vivo ELISpot assay86
Acquired fluconazole resistance and genetic clustering in Diutina (Candida) catenulata from clinical samples86
Pharmacokinetics/pharmacodynamics of phage therapy: a major hurdle to clinical translation85
Antibiotic resistance associated with the COVID-19 pandemic: a systematic review and meta-analysis83
Pathogen and host determinants of extrapulmonary tuberculosis among 1035 patients in Frankfurt am Main, Germany, 2008–202383
PRAISE: providing a roadmap for automated infection surveillance in Europe78
Non-biomedical factors affecting antibiotic use in the community: a mixed-methods systematic review and meta-analysis78
The diagnostic value of serum Borrelia burgdorferi antibodies and seroconversion after Lyme neuroborreliosis, a nationwide observational study76
Respiratory syncytial virus in adults with comorbidities: an update on epidemiology, vaccines, and treatments75
Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review74
Re: ‘Heightened incidence of adverse events associated with a live attenuated varicella vaccine strain that lacks critical genetic polymorphisms in ORF62’ by Kim et al.72
Diagnostic accuracy of self-collected tongue swabs for Mycobacterium tuberculosis complex detection in individuals being assessed for tuberculosis in South Africa using the Xpert MTB/RIF Ultra assay72
Oral step-down with β-lactams for uncomplicated Enterobacterales bacteraemia71
Clinical, virologic and immunologic features of a mild case of SARS-CoV-2 reinfection68
Real-world effectiveness of nirmatrelvir/ritonavir against COVID-19 hospitalizations and severe COVID-19 in community-dwelling elderly Singaporeans during Omicron BA.2, BA.4/5, and XBB transmission67
Effect of antiseptic bathing with chlorhexidine or octenidine on central line–associated bloodstream infections in intensive care patients: a cluster-randomized controlled trial66
Which trial do we need? Next-generation sequencing to individualize therapy in Staphylococcus aureus bacteraemia65
Inferring antibiotic susceptibility from metagenomic data: dream or reality?63
Safety of pertussis vaccination in pregnancy and effectiveness in infants: a Danish national cohort study 2019–202362
Detection of viable SARS-CoV-2 in retrospective analysis of aerosol samples collected from hospital rooms of patients with COVID-1961
A chronic infectious bladder stone causing an obstructive emphysematous cystitis58
Fulminant cytokine release syndrome in a paediatric patient with refractory Epstein–Barr virus-associated haemophagocytic lymphohistiocytosis receiving nivolumab treatment58
Anti-SARS-CoV-2 antibody response after 2 and 3 doses of BNT162b2 mRNA vaccine in patients with lymphoid malignancies57
Accuracy of cholera rapid diagnostic tests: a systematic review and meta-analysis57
In vitro activity of the novel siderophore cephalosporin, cefiderocol, in Gram-negative pathogens in Europe by site of infection57
0.66822218894958